Back

AXIOMATIC-SSP: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention.

28 August 2022 (09:36 - 09:48)
Organised by:
Congress Presentation Part of: HOT LINE SESSION 5 Prevention ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Mukul Sharma

Population Health Research Institute, Hamilton (Canada)

11 More presentations in this session

Presentation thumbnail
INVICTUS - Rivaroxaban versus VKA for rheumatic atrial fibrillation.
Professor G. Karthikeyan (New Delhi, IN)
Slides Video
Presentation thumbnail
Discussant review - INVICTUS.
Professor R. Lopes (Durham, US)
Slides Video
Presentation thumbnail
Panel discussion - INVICTUS.
Video
Presentation thumbnail
PACIFIC-AMI - Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction .
Professor J. Alexander (Durham, US)
Slides Video
Presentation thumbnail
Discussant review - PACIFIC-AMI.
Doctor M. O'Donoghue (Boston, US)
Slides Video

Access the full session

Session thumbnail
HOT LINE SESSION 5
Video

The Event

Event poster

ESC Congress 2022

28 August 2022 09:36 CET
You may be interested in
thumbnail
Congress Presentation
Factor XI inhibition: clinical view on current research and future implications
30 August 2024
thumbnail
Congress Presentation
HI-PRO: Apixaban for Extended Treatment of Provoked Venous Thromboembolism
30 August 2025
thumbnail
Congress Presentation
A multicenter, randomized, double-blind, placebo-controlled, parallel group study on the safety and efficacy of istaroxime for pre-cardiogenic shock
19 May 2025
thumbnail
Congress Presentation
Managing stroke patients with indications for both anticoagulant and antiplatelet treatment
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources